GlaxoSmithKline: It is expected to launch 22 phase III clinical trials in 2026, and 18 have been initiated so far.

Zhitongcaijing · 5d ago
GlaxoSmithKline: It is expected to launch 22 phase III clinical trials in 2026, and 18 have been initiated so far.